Role of radical prostatectomy in patients with prostate cancer of high Gleason score

Prostate

Volumn 39, Issue 1, 1999, Pages 60-66

  Tefilli, Marcos V ^a   Gheiler, Edward L ^a   Tiguert, Rabi ^a   Banerjee, Mousumi ^a   Sakr, Wael ^a   Grignon, David ^a   Wood Jr , David P ^a   Pontes, J Edson ^a,b  

^a WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NONE   (United States)

Author keywords

Prognosis; Prostate cancer; Radical prostatectomy

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADULT; AGED; ARTICLE; CANCER DIAGNOSIS; CANCER GRADING; CANCER REGISTRY; CANCER STAGING; CANCER SURVIVAL; DATA ANALYSIS; DATA BASE; FOLLOW UP; HISTOPATHOLOGY; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; MALE; PREOPERATIVE PERIOD; PRIORITY JOURNAL; PROGNOSIS; PROSTATE CANCER; PROSTATECTOMY; SURVIVAL TIME; TUMOR VOLUME;

ADULT; AGED; HUMANS; MALE; MIDDLE AGED; NEOPLASM STAGING; PROGNOSIS; PROSTATECTOMY; PROSTATIC NEOPLASMS; SURVIVAL RATE;

EID: 0033560009     PISSN: 02704137     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0045(19990401)39:1<60::AID-PROS10>3.0.CO;2-U     Document Type: Article

References (30)

1. Zincke H, Oesterling JE, Blute ML, Bergstrahl EJ, Meyers RP, Barret DM. Long-term (15 years) results after radical prostatectomy for clinically localized (stage T2c or lower) prostate cancer. J Urol 1994;152:1850-1857.
2. Jewett HJ, Bridge RW, Gray GF Jr, Shelley WM. The palpable nodule of prostate cancer. Results 15 years after radical excision. JAMA 1968;203:403-406.
3. Lerner SE, Blute ML, Bergstralh EJ, Bostwick DG, Eickolt JT, Zincke H. Analysis of risk factors of progression in patients with pathologically confined prostate cancer after radical retropubic prostatectomy. J Urol 1996;156:137-143.
4. Fleming C, Wasson JH, Albertsen PC, Barry MJ, Wennberg JE. A decision analysis of alternative treatment strategies for clinically localized prostate cancer. Prostate Patients Outcomes Research Team. JAMA 1993;269:2650-2658.
5. Gleason DF, Mellinger GT. The Veterans Administration Cooperative Urological Research Group: prediction of prognosis for prostatic carcinoma by combined histological grading and clinical staging. J Urol 1974;111:58-64.
6. Fowler JE, Mills SE. Operable prostatic carcinoma: correlations among clinical stage, pathological stage, Gleason histological score and early disease-free survival. J Urol 1984;133:49-51.
7. Partin AW, Yoo J, Carter HB, Pearson JD, Chan DW, Epstein JI, Walsh PC. The use of prostate specific antigen, clinical stage and Gleason score to predict pathological stage in men with localized prostate cancer. J Urol 1993;150:110-114.
8. Epstein JI, Carmichael M, Partin AW, Walsh PC. Is tumor volume an independent predictor of progression following radical prostatectomy? A multivariate analysis of 185 clinical stage B adenocarcinomas of the prostate with 5 years of follow up. J Urol 1993;149:1478-1481.
9. Fernandes ET, Sundaram CP, Long R, Soltani M, Ercole CJ. Biopsy Gleason score: how does it correlate with the final pathological diagnosis in prostate cancer? Br J Urol 1997;79:615-617.
10. Cookson MS, Fleshner NE, Soloway SM, Fair WR. Correlation between Gleason score on needle biopsy and radical prostatectomy specimen: accuracy and clinical implications. J Urol 1997; 157:559-562.
11. Egawa S, Shoji K, Uchida T, Kuwao S, Koshiba K. Long-term impact of conservative management on localized prostate cancer. Urology 1993;42:520-526.
12. Walsh PC, Jewett HJ. Radical surgery for prostate cancer. Cancer 1980;45:1906-1911.
13. Perroti M, Rabbani F, Russo P, Solomon MC, Fair WR. Early prostate cancer detection and potential for surgical cure in men with poorly differentiated tumors. Urology 1998;52:106-110.
14. Schroder FH, Hermanck P, Denis L, Fair WR, Gospodarowicz MK, Pavone-Macaluso M. The TNM classification of prostate cancer. Prostate [Suppl] 1992;4:129-138.
15. Palken M, Cobb OE, Warren BH, Hoak DC. Prostate cancer: correlation of digital rectal examination, transrectal ultrasound and prostate specific antigen levels with tumor volume in radical prostatectomy specimens. J Urol 1990;143:1155-1162.
16. Paulson DF, Moul JW, Walther PJ. Radical prostatectomy for clinical stage T1-2N0M0 prostatic adenocarcinoma: long-term results. J Urol 1990;144:1180-1184.
17. Oefelein MG, Smith ND, Grayhack JT, Schaeffer AJ, McVary KT. Long-term results of radical retropubic prostatectomy in men with high grade carcinoma of the prostate. J Urol 1997;158:1460-1465.
18. Ohori M, Goad JR, Wheeler TM, Eastham JA, Thompson TC, Scardino PT. Can radical prostatectomy alter the progression of poorly differentiated prostate cancer? J Urol 1994;152:1843-1849.
19. Partin AW, Pound CR, Clemens JQ, Epstein JI, Walsh PC. Serum PSA after anatomic radical prostatectomy. The Johns Hopkins experience after 10 years. Urol Clin North Am 1993;20:713-725.
20. Zagars GK. Serum PSA as a tumor marker for patients undergoing definitive radiation therapy. Urol Clin North Am 1993; 20:737-747.
21. Terris MK, Haney DJ, Johnstone IM, McNeal JE, Stamey TA. Prediction of prostate cancer volume using prostate-specific antigen levels, transrectal ultrasound, and systematic sextant biopsies. Urology 1995;45:75-80.
22. McNeal JE. Cancer volume and site of origin of adenocarcinoma in the prostate: relationship to local and distant spread. Hum Pathol 1992;23:258-266.
23. McNeal JE, Villers AA, Redwine EA, Freiha FS, Stamey TA. Histologic differentiation, cancer volume, and pelvic lymph node metastasis in adenocarcinoma of the prostate. Cancer 1990; 66:1225-1233.
24. Gheiler EL, Lovisolo JA, Tiguert R, Tefilli MV, Grayson T, Olford G, Powell IJ, Oldford G, Famiglietti G, Banerjee M, Pontes JE, Wood DP Jr. Results of a clinical care pathway for radical prostatectomy patients in a multiphysician-open hospital system. Eur Urol 1999; in press.
25. Epstein JI, Pizov G, Walsh PC. Correlation of pathologic findings with progression following radical retropubic prostatectomy. Cancer 1993;71:3582-3593.
26. Paulson DF. Impact of radical prostatectomy in the management of clinically localized disease. J Urol 1994;152:1826-1830.
27. Ohori M, Wheeler TM, Kattan MW, Goto Y, Scardino P. Prognostic significance of positive surgical margins in radical prostatectomy specimens. J Urol 1995;154:1818-1824.
28. Partin AW, Borland RN, Epstein JI, Brendler CB. Influence of wide excision of the neurovascular bundle(s) on prognosis in men with clinically localized prostate cancer with established capsular penetration. J Urol 1993;150:142-146.
29. Smith RC, Partin AW, Epstein JI, Brendler CB. Extended follow up of the influence of wide excision of the neurovascular bundle(s) on prognosis in men with clinically localized prostate cancer and extensive capsular perforation. J Urol 1996;156:454-457.
30. Partin AW, Lee BR, Carmichael M, Walsh PC, Epstein JI. Radical prostatectomy for high grade disease: a reevaluation 1994. J Urol 1994;151:1583-1586.